Published in Biomaterials on October 24, 2007
Accordion-like honeycombs for tissue engineering of cardiac anisotropy. Nat Mater (2008) 4.00
Engineering retinal progenitor cell and scrollable poly(glycerol-sebacate) composites for expansion and subretinal transplantation. Biomaterials (2009) 1.18
A tissue-engineered approach towards retinal repair: scaffolds for cell transplantation to the subretinal space. Graefes Arch Clin Exp Ophthalmol (2010) 1.10
Toll-like receptor 4 restricts retinal progenitor cell proliferation. J Cell Biol (2008) 1.09
Microfabricated implants for applications in therapeutic delivery, tissue engineering, and biosensing. Lab Chip (2008) 0.99
Enhanced differentiation of retinal progenitor cells using microfabricated topographical cues. Biomed Microdevices (2010) 0.97
The significance of pore microarchitecture in a multi-layered elastomeric scaffold for contractile cardiac muscle constructs. Biomaterials (2010) 0.95
Electrospun chitosan-graft-poly (ɛ-caprolactone)/poly (ɛ-caprolactone) nanofibrous scaffolds for retinal tissue engineering. Int J Nanomedicine (2011) 0.95
Stem cell and biomaterials research in dental tissue engineering and regeneration. Dent Clin North Am (2012) 0.93
Guiding the morphogenesis of dissociated newborn mouse retinal cells and hES cell-derived retinal cells by soft lithography-patterned microchannel PLGA scaffolds. Biomaterials (2011) 0.86
Three-dimensional elastomeric scaffolds designed with cardiac-mimetic structural and mechanical features. Tissue Eng Part A (2012) 0.86
A novel family of biodegradable poly(ester amide) elastomers. Adv Mater (2011) 0.86
Scaffolds and stem cells: delivery of cell transplants for retinal degenerations. Expert Rev Ophthalmol (2012) 0.85
Differential expression of neuronal genes in Müller glia in two- and three-dimensional cultures. Invest Ophthalmol Vis Sci (2011) 0.84
Retinal transplantation using surface modified poly(glycerol-co-sebacic acid) membranes. Biomaterials (2010) 0.83
Stem cells: a new paradigm for disease modeling and developing therapies for age-related macular degeneration. J Transl Med (2013) 0.83
Current treatment limitations in age-related macular degeneration and future approaches based on cell therapy and tissue engineering. J Ophthalmol (2014) 0.82
Topographical control of ocular cell types for tissue engineering. J Biomed Mater Res B Appl Biomater (2013) 0.82
Micro/nano-fabrication technologies for cell biology. Med Biol Eng Comput (2010) 0.82
Preparation and characterization of microporous poly(D,L-lactic acid) film for tissue engineering scaffold. Int J Nanomedicine (2010) 0.81
Selective removal of photoreceptor cells in vivo using the biodegradable elastomer poly(glycerol sebacate). Tissue Eng Part A (2009) 0.81
A functionalizable polyester with free hydroxyl groups and tunable physiochemical and biological properties. Biomaterials (2010) 0.79
Engineering of the embryonic and adult stem cell niches. Iran Red Crescent Med J (2013) 0.79
Biomimetic scaffold combined with electrical stimulation and growth factor promotes tissue engineered cardiac development. Exp Cell Res (2013) 0.78
Enhanced differentiation and delivery of mouse retinal progenitor cells using a micropatterned biodegradable thin-film polycaprolactone scaffold. Tissue Eng Part A (2015) 0.77
Differentiation of Induced Pluripotent Stem Cells to Neural Retinal Precursor Cells on Porous Poly-Lactic-co-Glycolic Acid Scaffolds. J Ocul Pharmacol Ther (2015) 0.75
Novel Strategies for the Improvement of Stem Cells' Transplantation in Degenerative Retinal Diseases. Stem Cells Int (2016) 0.75
A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol (2001) 21.37
Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol (2004) 18.86
Rapid Prototyping of Microfluidic Systems in Poly(dimethylsiloxane). Anal Chem (1998) 15.53
A randomized trial of vitamin A and vitamin E supplementation for retinitis pigmentosa. Arch Ophthalmol (1993) 7.73
Retinal repair by transplantation of photoreceptor precursors. Nature (2006) 6.73
Nrl is required for rod photoreceptor development. Nat Genet (2001) 5.68
Solvent compatibility of poly(dimethylsiloxane)-based microfluidic devices. Anal Chem (2003) 5.51
Porous scaffold design for tissue engineering. Nat Mater (2005) 5.00
A tough biodegradable elastomer. Nat Biotechnol (2002) 4.35
Population genetic studies of retinitis pigmentosa. Am J Hum Genet (1980) 3.51
Risk factors for neovascular age-related macular degeneration. The Eye Disease Case-Control Study Group. Arch Ophthalmol (1992) 2.71
Apoptotic photoreceptor degeneration in experimental retinal detachment. Invest Ophthalmol Vis Sci (1995) 2.24
Endothelialized microvasculature based on a biodegradable elastomer. Tissue Eng (2005) 2.23
Biomimetic approach to cardiac tissue engineering: oxygen carriers and channeled scaffolds. Tissue Eng (2006) 2.20
Multipotent retinal progenitors express developmental markers, differentiate into retinal neurons, and preserve light-mediated behavior. Invest Ophthalmol Vis Sci (2004) 2.10
Ranibizumab for treatment of neovascular age-related macular degeneration: a phase I/II multicenter, controlled, multidose study. Ophthalmology (2006) 2.07
Neuronal differentiation and morphological integration of hippocampal progenitor cells transplanted to the retina of immature and mature dystrophic rats. Mol Cell Neurosci (2000) 2.07
Photoreceptor apoptosis in human retinal detachment. Am J Ophthalmol (2005) 2.03
In vivo degradation characteristics of poly(glycerol sebacate). J Biomed Mater Res A (2003) 2.01
Biocompatibility analysis of poly(glycerol sebacate) as a nerve guide material. Biomaterials (2005) 1.93
Further evaluation of docosahexaenoic acid in patients with retinitis pigmentosa receiving vitamin A treatment: subgroup analyses. Arch Ophthalmol (2004) 1.80
Multiple phosphorylated isoforms of NRL are expressed in rod photoreceptors. J Biol Chem (2001) 1.79
Topography of the retinal thickness in normal subjects. Ophthalmology (1990) 1.79
Implantable biohybrid artificial organs. Cell Transplant (1995) 1.65
Widespread integration and survival of adult-derived neural progenitor cells in the developing optic retina. Mol Cell Neurosci (1998) 1.62
Biodegradable polymer composite grafts promote the survival and differentiation of retinal progenitor cells. Stem Cells (2005) 1.50
Macroporous elastomeric scaffolds with extensive micropores for soft tissue engineering. Tissue Eng (2006) 1.48
Limiting photoreceptor death and deconstruction during experimental retinal detachment: the value of oxygen supplementation. Am J Ophthalmol (1999) 1.47
Hemocompatibility evaluation of poly(glycerol-sebacate) in vitro for vascular tissue engineering. Biomaterials (2006) 1.38
Fabrication of degradable polymer scaffolds to direct the integration and differentiation of retinal progenitors. Biomaterials (2005) 1.38
Stem cells and retinal repair. Prog Retin Eye Res (2004) 1.36
Progenitor cells from the porcine neural retina express photoreceptor markers after transplantation to the subretinal space of allorecipients. Stem Cells (2007) 1.25
An analysis of the gene expression program of mammalian neural progenitor cells. Proc Natl Acad Sci U S A (2004) 1.25
An investigation of the role of cavitation in low-frequency ultrasound-mediated transdermal drug transport. Pharm Res (2002) 1.23
Survival, migration and differentiation of retinal progenitor cells transplanted on micro-machined poly(methyl methacrylate) scaffolds to the subretinal space. Lab Chip (2007) 1.13
Correlation between surface free energy and surface constitution. Science (1992) 1.11
Retinal and optic nerve diseases. Artif Organs (2003) 1.10
Retinal progenitor cell xenografts to the pig retina: morphologic integration and cytochemical differentiation. Arch Ophthalmol (2005) 1.06
Ocular immune privilege and the Faustian dilemma. The Proctor lecture. Invest Ophthalmol Vis Sci (1996) 0.98
Biomechanical characteristics of retina. Retina (2004) 0.95
Neurobiology: right timing for retina repair. Nature (2006) 0.95
Stem cells in the mammalian eye: a tool for retinal repair. APMIS (2006) 0.89
Treatment of age-related macular degeneration. Clin Exp Optom (2005) 0.89
Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol (2007) 17.80
Knocking down barriers: advances in siRNA delivery. Nat Rev Drug Discov (2009) 12.46
Engineering vascularized skeletal muscle tissue. Nat Biotechnol (2005) 7.73
Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo. Proc Natl Acad Sci U S A (2006) 6.90
Impact of nanotechnology on drug delivery. ACS Nano (2009) 6.87
A combinatorial library of lipid-like materials for delivery of RNAi therapeutics. Nat Biotechnol (2008) 6.81
Microscale technologies for tissue engineering and biology. Proc Natl Acad Sci U S A (2006) 6.66
Preclinical development and clinical translation of a PSMA-targeted docetaxel nanoparticle with a differentiated pharmacological profile. Sci Transl Med (2012) 5.92
Nanoliter-scale synthesis of arrayed biomaterials and application to human embryonic stem cells. Nat Biotechnol (2004) 5.51
Transdermal drug delivery. Nat Biotechnol (2008) 5.11
Adipose tissue mass can be regulated through the vasculature. Proc Natl Acad Sci U S A (2002) 4.77
Therapeutic RNAi targeting PCSK9 acutely lowers plasma cholesterol in rodents and LDL cholesterol in nonhuman primates. Proc Natl Acad Sci U S A (2008) 4.57
Nanoparticle-aptamer bioconjugates: a new approach for targeting prostate cancer cells. Cancer Res (2004) 4.56
Combined postmenopausal hormone therapy and cardiovascular disease: toward resolving the discrepancy between observational studies and the Women's Health Initiative clinical trial. Am J Epidemiol (2005) 4.55
Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events. Nat Biotechnol (2008) 4.46
A tough biodegradable elastomer. Nat Biotechnol (2002) 4.35
Lipid-like materials for low-dose, in vivo gene silencing. Proc Natl Acad Sci U S A (2010) 4.25
Functional assembly of engineered myocardium by electrical stimulation of cardiac myocytes cultured on scaffolds. Proc Natl Acad Sci U S A (2004) 4.13
Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery. Biomaterials (2006) 4.09
Exploring polyethylenimine-mediated DNA transfection and the proton sponge hypothesis. J Gene Med (2005) 4.04
Accordion-like honeycombs for tissue engineering of cardiac anisotropy. Nat Mater (2008) 4.00
A reversibly switching surface. Science (2003) 3.97
Therapeutic siRNA silencing in inflammatory monocytes in mice. Nat Biotechnol (2011) 3.95
Small-scale systems for in vivo drug delivery. Nat Biotechnol (2003) 3.90
Precise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymers. Proc Natl Acad Sci U S A (2008) 3.80
Nanoparticle delivery of cancer drugs. Annu Rev Med (2011) 3.75
Endothelial cells derived from human embryonic stem cells. Proc Natl Acad Sci U S A (2002) 3.66
Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA-PEG nanoparticles. Proc Natl Acad Sci U S A (2008) 3.62
First-in-human testing of a wirelessly controlled drug delivery microchip. Sci Transl Med (2012) 3.56
Endogenous VEGF is required for visual function: evidence for a survival role on müller cells and photoreceptors. PLoS One (2008) 3.46
Controlled degradation and mechanical behavior of photopolymerized hyaluronic acid networks. Biomacromolecules (2005) 3.44
Current status and future potential of transdermal drug delivery. Nat Rev Drug Discov (2004) 3.41
Oncomodulin is a macrophage-derived signal for axon regeneration in retinal ganglion cells. Nat Neurosci (2006) 3.35
Functional recovery following traumatic spinal cord injury mediated by a unique polymer scaffold seeded with neural stem cells. Proc Natl Acad Sci U S A (2002) 3.35
Treating metastatic cancer with nanotechnology. Nat Rev Cancer (2011) 3.30
Hyaluronic acid hydrogel for controlled self-renewal and differentiation of human embryonic stem cells. Proc Natl Acad Sci U S A (2007) 3.19
Outbreak of adverse reactions associated with contaminated heparin. N Engl J Med (2008) 3.16
Nanotechnological strategies for engineering complex tissues. Nat Nanotechnol (2010) 3.15
Combinatorial development of biomaterials for clonal growth of human pluripotent stem cells. Nat Mater (2010) 3.11
Molecularly self-assembled nucleic acid nanoparticles for targeted in vivo siRNA delivery. Nat Nanotechnol (2012) 3.09
Engineering substrate topography at the micro- and nanoscale to control cell function. Angew Chem Int Ed Engl (2009) 3.09
Microengineered hydrogels for tissue engineering. Biomaterials (2007) 2.87
Transplantation of adult mouse iPS cell-derived photoreceptor precursors restores retinal structure and function in degenerative mice. PLoS One (2011) 2.86
Differentiation of human embryonic stem cells on three-dimensional polymer scaffolds. Proc Natl Acad Sci U S A (2003) 2.86
Isolation and characterization of neural progenitor cells from post-mortem human cortex. J Neurosci Res (2003) 2.86
Semi-automated synthesis and screening of a large library of degradable cationic polymers for gene delivery. Angew Chem Int Ed Engl (2003) 2.83
The inflammatory responses to silk films in vitro and in vivo. Biomaterials (2005) 2.79
Biodegradable, elastic shape-memory polymers for potential biomedical applications. Science (2002) 2.79
Self-assembled lipid--polymer hybrid nanoparticles: a robust drug delivery platform. ACS Nano (2008) 2.76
Nanomedicine: developing smarter therapeutic and diagnostic modalities. Adv Drug Deliv Rev (2006) 2.69
Multi-pulse drug delivery from a resorbable polymeric microchip device. Nat Mater (2003) 2.65
A combinatorial polymer library approach yields insight into nonviral gene delivery. Acc Chem Res (2008) 2.63
A biodegradable and biocompatible gecko-inspired tissue adhesive. Proc Natl Acad Sci U S A (2008) 2.58
Macroporous nanowire nanoelectronic scaffolds for synthetic tissues. Nat Mater (2012) 2.57
Light-induced shape-memory polymers. Nature (2005) 2.52
Risk of cardiovascular disease by hysterectomy status, with and without oophorectomy: the Women's Health Initiative Observational Study. Circulation (2005) 2.49
Medium perfusion enables engineering of compact and contractile cardiac tissue. Am J Physiol Heart Circ Physiol (2003) 2.42
Quantum dot-aptamer conjugates for synchronous cancer imaging, therapy, and sensing of drug delivery based on bi-fluorescence resonance energy transfer. Nano Lett (2007) 2.40
A vector-free microfluidic platform for intracellular delivery. Proc Natl Acad Sci U S A (2013) 2.40
Development of lipidoid-siRNA formulations for systemic delivery to the liver. Mol Ther (2009) 2.39
An aptamer-doxorubicin physical conjugate as a novel targeted drug-delivery platform. Angew Chem Int Ed Engl (2006) 2.38
Bio-inspired polymer composite actuator and generator driven by water gradients. Science (2013) 2.38
Nanotechnology in drug delivery and tissue engineering: from discovery to applications. Nano Lett (2010) 2.35
Controlling size, shape and homogeneity of embryoid bodies using poly(ethylene glycol) microwells. Lab Chip (2007) 2.30
Biocompatibility and biofouling of MEMS drug delivery devices. Biomaterials (2003) 2.27
Bone tissue engineering using human mesenchymal stem cells: effects of scaffold material and medium flow. Ann Biomed Eng (2004) 2.26
Endothelialized microvasculature based on a biodegradable elastomer. Tissue Eng (2005) 2.23
Silk implants for the healing of critical size bone defects. Bone (2005) 2.22
PLGA-lecithin-PEG core-shell nanoparticles for controlled drug delivery. Biomaterials (2008) 2.21
Engineering of self-assembled nanoparticle platform for precisely controlled combination drug therapy. Proc Natl Acad Sci U S A (2010) 2.21
Biomimetic approach to cardiac tissue engineering: oxygen carriers and channeled scaffolds. Tissue Eng (2006) 2.20
Micromolding of shape-controlled, harvestable cell-laden hydrogels. Biomaterials (2006) 2.12
Nanostructured materials for applications in drug delivery and tissue engineering. J Biomater Sci Polym Ed (2007) 2.12
Vascular progenitor cells isolated from human embryonic stem cells give rise to endothelial and smooth muscle like cells and form vascular networks in vivo. Circ Res (2007) 2.12
Multipotent retinal progenitors express developmental markers, differentiate into retinal neurons, and preserve light-mediated behavior. Invest Ophthalmol Vis Sci (2004) 2.10
Progress in tissue engineering. Sci Am (2009) 2.08
In vivo engineering of organs: the bone bioreactor. Proc Natl Acad Sci U S A (2005) 2.04
Molecularly engineered poly(ortho ester) microspheres for enhanced delivery of DNA vaccines. Nat Mater (2004) 2.03
Poly-beta amino ester-containing microparticles enhance the activity of nonviral genetic vaccines. Proc Natl Acad Sci U S A (2004) 2.03
Oxygen gradients correlate with cell density and cell viability in engineered cardiac tissue. Biotechnol Bioeng (2006) 2.01
In vivo degradation characteristics of poly(glycerol sebacate). J Biomed Mater Res A (2003) 2.01
Efficiency of siRNA delivery by lipid nanoparticles is limited by endocytic recycling. Nat Biotechnol (2013) 1.97
Engineering bone-like tissue in vitro using human bone marrow stem cells and silk scaffolds. J Biomed Mater Res A (2004) 1.94
Measurement and predictors of resilience among community-dwelling older women. J Psychiatr Res (2008) 1.91
Cell docking inside microwells within reversibly sealed microfluidic channels for fabricating multiphenotype cell arrays. Lab Chip (2005) 1.89
Structure/property studies of polymeric gene delivery using a library of poly(beta-amino esters). Mol Ther (2005) 1.87
Synthesis of poly(beta-amino ester)s optimized for highly effective gene delivery. Bioconjug Chem (2003) 1.87
Gold, poly(beta-amino ester) nanoparticles for small interfering RNA delivery. Nano Lett (2009) 1.86
Quantitative and comparative studies of the vocal fold extracellular matrix II: collagen. Ann Otol Rhinol Laryngol (2006) 1.85
A simple soft lithographic route to fabrication of poly(ethylene glycol) microstructures for protein and cell patterning. Biomaterials (2004) 1.84
Genetic engineering of human stem cells for enhanced angiogenesis using biodegradable polymeric nanoparticles. Proc Natl Acad Sci U S A (2009) 1.83
New opportunities: the use of nanotechnologies to manipulate and track stem cells. Cell Stem Cell (2008) 1.82
Parallel synthesis and biophysical characterization of a degradable polymer library for gene delivery. J Am Chem Soc (2003) 1.81
Microfluidic platform for controlled synthesis of polymeric nanoparticles. Nano Lett (2008) 1.80
A polymer library approach to suicide gene therapy for cancer. Proc Natl Acad Sci U S A (2004) 1.79
Co-culture of human embryonic stem cells with murine embryonic fibroblasts on microwell-patterned substrates. Biomaterials (2006) 1.79
Biomaterial microarrays: rapid, microscale screening of polymer-cell interaction. Biomaterials (2005) 1.78
Fabrication and biocompatibility of polypyrrole implants suitable for neural prosthetics. Biomaterials (2005) 1.78
High-density seeding of myocyte cells for cardiac tissue engineering. Biotechnol Bioeng (2003) 1.77